- Home
- AEHR vs SAGE Comparison
AEHR vs SAGE Comparison
Compare AEHR & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHR
- SAGE
- Stock Information
- Founded
- AEHR 1977
- SAGE 2010
- Country
- AEHR United States
- SAGE United States
- Employees
- AEHR N/A
- SAGE N/A
- Industry
- AEHR Electrical Products
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- AEHR Industrials
- SAGE Health Care
- Exchange
- AEHR Nasdaq
- SAGE Nasdaq
- Market Cap
- AEHR 451.1M
- SAGE 462.2M
- IPO Year
- AEHR 1997
- SAGE 2014
- Fundamental
- Price
- AEHR $11.70
- SAGE $4.85
- Analyst Decision
- AEHR Hold
- SAGE Hold
- Analyst Count
- AEHR 2
- SAGE 20
- Target Price
- AEHR $12.00
- SAGE $12.83
- AVG Volume (30 Days)
- AEHR 1.1M
- SAGE 906.7K
- Earning Date
- AEHR 01-07-2025
- SAGE 10-29-2024
- Dividend Yield
- AEHR N/A
- SAGE N/A
- EPS Growth
- AEHR 53.60
- SAGE N/A
- EPS
- AEHR 0.98
- SAGE N/A
- Revenue
- AEHR $58,713,000.00
- SAGE $106,399,000.00
- Revenue This Year
- AEHR $9.15
- SAGE N/A
- Revenue Next Year
- AEHR $29.87
- SAGE $118.26
- P/E Ratio
- AEHR $11.91
- SAGE N/A
- Revenue Growth
- AEHR N/A
- SAGE 837.60
- 52 Week Low
- AEHR $9.83
- SAGE $4.62
- 52 Week High
- AEHR $30.50
- SAGE $28.26
- Technical
- Relative Strength Index (RSI)
- AEHR 42.52
- SAGE 28.50
- Support Level
- AEHR $10.97
- SAGE $4.62
- Resistance Level
- AEHR $11.41
- SAGE $5.87
- Average True Range (ATR)
- AEHR 0.67
- SAGE 0.39
- MACD
- AEHR -0.10
- SAGE -0.12
- Stochastic Oscillator
- AEHR 43.98
- SAGE 11.33
About AEHR Aehr Test Systems
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.